← Back

MRNAModerna

$141.97-2.46%Real quote · delayedmRNA vaccines

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $1.9B · latest quarter up 2.1% YoY · not yet profitable (FY net loss $2.8B) · short activity within its normal range.

FY revenue

$1.9B

2025-12

Latest Q YoY

+2.1%

FY net loss

$2.8B

Diluted EPS

$-7.26

Short volume

54.1%

20d avg 59.1% · normal

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

2026-08-12passive (13G)Capital World Investors
2026-08-06passive (13G)FMR LLC
2026-07-24passive (13G)BAILLIE GIFFORD & CO
2026-04-30passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
2026-03-27passive (13G)VANGUARD GROUP INC

🎯 Market expectations

Expectation reliability Low · 35/100

Nasdaq analyst consensus · the pre-news baseline

There is no clear consensus on this stock (thin coverage or wide disagreement) — 'beating expectations' means little here.

Next quarter (Sep 2026) consensus-$1.08Estimate range -$1.35 ~ -$0.76 · 7 analystsRevisions (4w):↑2↓1

History: actual vs consensusavg +39%

Jun 2026-$1.97 vs -$1.970%
Mar 2026-$1.18 vs -$3.02+60.93%
Dec 2025-$2.11 vs -$2.60+18.85%
Sep 2025-$0.51 vs -$2.15+76.28%

Analyst estimates, not our forecast · not investment advice

What's moving this stock lately

2 direct · 0 2nd-order · 0 thematic

Ranked by impact strength · strength = estimated move × freshness decay (shorter-lived effects decay faster)

#1▲2.32%DirectThe Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.4d ago
The Merck-partnered individualized neoantigen therapy is Moderna's key non-COVID growth story; heightened media attention raises focus on a potential 2027 approval
Impact chain →
Also named: BNTX · MRK · PSNL · ADPT · ILMN · TMO
#2▲0.36%DirectBeyond NVDA: New Frontiers in Space Stocks, Healthcare AI3d ago
Listed as a representative healthcare-AI theme company; may briefly lift attention but lacks concrete AI R&D progress or order information to support a sustained move.
Impact chain →
Also named: LUNR · ASTS · RKLB · PL · LMT · NVDA

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

The 16 engine calls on this chart (hit / miss / pending) are Pro — price and volume only for now▂ volume

📜 Call history (newest first

🔒 Pro only

16 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view

🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.